|
KHNYN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.394900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.790160E-02 |
| Normal-vs-Stage2 |
3.055800E-02 |
| Normal-vs-Stage3 |
1.230560E-01 |
| Normal-vs-Stage4 |
7.565000E-01 |
| Stage1-vs-Stage2 |
5.380600E-01 |
| Stage1-vs-Stage3 |
8.783600E-01 |
| Stage1-vs-Stage4 |
7.591800E-02 |
| Stage2-vs-Stage3 |
7.572400E-01 |
| Stage2-vs-Stage4 |
7.845800E-02 |
| Stage3-vs-Stage4 |
1.365620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.635700E-04 |
| Normal-vs-AfricanAmerican |
1.700270E-02 |
| Normal-vs-Asian |
8.543600E-01 |
| Caucasian-vs-AfricanAmerican |
7.470000E-01 |
| Caucasian-vs-Asian |
9.900100E-03 |
| AfricanAmerican-vs-Asian |
2.913800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.241200E-03 |
| Normal-vs-Female |
1.384070E-03 |
| Male-vs-Female |
1.268590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.915600E-01 |
| Normal-vs-Extreme_Weight |
1.062650E-01 |
| Normal-vs-Obese |
7.623100E-04 |
| Normal-vs-Extreme_Obese |
9.001000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.050200E-01 |
| Normal_Weight-vs-Obese |
1.465950E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.686600E-01 |
| Extreme_Weight-vs-Obese |
5.192000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.155800E-01 |
| Obese-vs-Extreme_Obese |
2.633800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.847520E-02 |
| Normal-vs-Age(41-60Yrs) |
8.22430000000374E-05 |
| Normal-vs-Age(61-80Yrs) |
2.037600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.469400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.661600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.884800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.433900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.264170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.224100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.387800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.71270000000257E-05 |
| Normal-VS-Type2 PRCC |
5.571000E-01 |
| Normal-VS-KIRP CIMP |
3.575600E-02 |
| Normal-VS-Unclassified PRCC |
2.498000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.44849999994534E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.644000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.061400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.755000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.181900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.384000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.079000E-01 |
| Normal-vs-N1 |
1.284410E-02 |
| Normal-vs-N2 |
6.370800E-01 |
| N0-vs-N1 |
1.940460E-02 |
| N0-vs-N2 |
6.429000E-01 |
| N1-vs-N2 |
1.779380E-01 |
|
|
